Johnson & Johnson Seeks to End Decade-Long Talc Litigation with $5.5 Billion Settlement
The voluntary deal would pay claims in full in less than two years, compared with 25 years under the failed bankruptcy plan.
8 Articles
8 Articles
Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About
Things are going well for the pharmaceutical giant.
Johnson & Johnson offers $5.5 billion to settle talc lawsuits
US pharmaceutical giant Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming that its talcum powder products caused ovarian cancer, the company said. The proposed settlement aims to end a long-standing legal battle that has weighed on the New Jersey-based firm for years. J&J said the settlement covers around […]...Keep on reading: Johnson & Johnson offers $5.5 billion to settle talc lawsuits
Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement
Johnson & Johnson has struck a substantial deal worth more than five billion dollars, aimed at settling numerous lawsuits that allege cancer linked to its talc products. Following an ineffective bankruptcy resolution attempt, this latest agreement will facilitate quicker claims disbursement while keeping the door open for others who develop cancer-related claims in the future.
Can J&J finally put the talc litigation behind it?
After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least US$5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade. What is the talc litigation about? Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other …
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium





